Gastrointestinal Stromal Tumors: Molecular Mechanisms and Targeted Therapies

Figure 1

KIT and PDGFRA with locations and frequency of activating mutations in GISTs. Exons denoted with an *represent those most frequently involved by secondary mutations. Modified with permission from Heinrich et al. [3]. Copyright 2003 by the American Society of Clinical Oncology. All rights reserved.